These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10593670

  • 1. Efficacy of lamotrigine and vigabatrin in drug-resistant epilepsies of childhood.
    Dimova PS, Korinthenberg R.
    Pediatr Neurol; 1999 Nov; 21(5):802-7. PubMed ID: 10593670
    [Abstract] [Full Text] [Related]

  • 2. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy.
    Kluger G, Berz K, Holthausen H.
    Eur J Paediatr Neurol; 2001 Nov; 5(1):37-40. PubMed ID: 11277363
    [Abstract] [Full Text] [Related]

  • 3. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG, Najam Y, Keegan MB, Whooley M, Madden D, McMenamin JB.
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [Abstract] [Full Text] [Related]

  • 4. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
    Bélanger S, Coulombe G, Carmant L.
    Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
    [Abstract] [Full Text] [Related]

  • 5. [In children with refractory epilepsy: vigabatrin or lamotrigine?].
    Caviedes BE, Herranz JL, Arteaga R, Armijo JA.
    Rev Neurol; 1998 Aug; 28(5):444-8. PubMed ID: 10229954
    [Abstract] [Full Text] [Related]

  • 6. A survey of lamotrigine and vigabatrin treatment in children with severe epilepsy.
    Schapel GJ, Wallace SJ, Gordon GS.
    Seizure; 1997 Dec; 6(6):479-83. PubMed ID: 9530945
    [Abstract] [Full Text] [Related]

  • 7. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
    Schapel G, Chadwick D.
    Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
    [Abstract] [Full Text] [Related]

  • 8. [Lamotrigine versus vigabatrin as an add-on therapy in refractory epilepsy: prospective study].
    Maciejek Z, Niezgodzińska-Maciejek A.
    Neurol Neurochir Pol; 2000 Dec; 34 Suppl 1():165-75. PubMed ID: 10768156
    [Abstract] [Full Text] [Related]

  • 9. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
    Hosford DA, Wang Y.
    Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
    [Abstract] [Full Text] [Related]

  • 10. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
    Prasad AN, Penney S, Buckley DJ.
    Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
    [Abstract] [Full Text] [Related]

  • 11. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA, Picard F, de Saint-Martin A, Strumia S, Marescaux C, Hirsch E.
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I, Piñol-Ripoll G, Khurana DS, Hardison HH, Kothare SV, Melvin JJ, Marks HG, Legido A.
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [Abstract] [Full Text] [Related]

  • 14. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE, Major P, Halpern E, Thiele EA.
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [Abstract] [Full Text] [Related]

  • 15. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H, Krämer G.
    Schweiz Med Wochenschr; 1995 Jan 28; 125(4):125-32. PubMed ID: 7878401
    [Abstract] [Full Text] [Related]

  • 16. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE.
    Epilepsia; 1994 Jan 28; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [Abstract] [Full Text] [Related]

  • 17. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).
    Donaldson JA, Glauser TA, Olberding LS.
    Epilepsia; 1997 Jan 28; 38(1):68-73. PubMed ID: 9024186
    [Abstract] [Full Text] [Related]

  • 18. Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom.
    Wong IC, Mawer GE, Sander JW.
    Epilepsia; 2001 Feb 28; 42(2):237-44. PubMed ID: 11240596
    [Abstract] [Full Text] [Related]

  • 19. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K, Connolly MB, Munn R, Peng S, MacWilliam LM.
    Pediatr Neurol; 1997 Apr 28; 16(3):201-5. PubMed ID: 9165509
    [Abstract] [Full Text] [Related]

  • 20. Adjunctive therapy for the treatment of primary generalized tonic-clonic seizures: focus on once-daily lamotrigine.
    Steinbaugh L, Szaflarski JP.
    Drug Des Devel Ther; 2010 Nov 18; 4():337-42. PubMed ID: 21151621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.